関連する実験動画
Updated: Jul 18, 2026

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
製薬業界は,政治的プレーヤーとしての役割を持っています
1Centre for Research in Health and Medicine, University of Sussex, BN1 9SN, Brighton, UK. j.w.abraham@sussex.ac.uk
Lancet (London, England)
|November 16, 2002
まとめ
医薬品産業の規制は,利益と公衆衛生の保護のバランスを取らなければならない. この研究は,製薬業界が薬物規制に及ぼす影響を調査し,より安全な医薬品の監督を強化するための方法を提案しています.
科学分野:
- 医薬品政策について
- 規制科学とは,規制に関する科学です.
- 公衆衛生は公衆衛生である.
背景:
- 製薬業界は不可欠な医薬品を提供しており,統治のための政治的枠組みが必要である.
- 不安全,無効,または不必要な薬から公衆衛生を保護するために,堅固な規制は不可欠です.
- 現在の薬物規制システムは,産業の影響によって損なわれ,公共の利益に不利になる可能性があります.
研究 の 目的:
- 医薬品規制プロセスに対する製薬業界の影響の範囲を分析する.
- 業界が政府や規制機関に影響を与えるメカニズムを特定する.
- 産業の不当な影響を軽減し,規制の強さを高めるための戦略を提案する.
主な方法:
- 製薬業界が規制機関に影響を与えるために使っている様々な方法についての議論.
- 産業に影響を与える政治・経済要因の分析.
- 既存の規制の枠組みと脆弱性の見直し
主要な成果:
- 製薬業界は,さまざまなチャネルを通じて,薬物規制に大きな影響を与えています.
- この影響は,規制監督の客観性と有効性を損なう可能性があります.
- 既存の規制システムは,産業の圧力から公衆衛生を適切に保護できない可能性があります.
結論:
- 製薬業界を統制する政治枠組みの強化は不可欠です.
- 産業の影響を抑制するための実施措置は,堅牢な薬物規制のために必要である.
- 医薬品の安全性,有効性,および公衆の利益のために必要性を確保するために,強化された監督は不可欠です.
関連する概念動画
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.

